Close
  Indian J Med Microbiol
 

Figure 2: Total mortality between implantable cardioverter defibrillator and control arm in dilated cardiomyopathy (DANISH trial[9]) and ischemic cardiomyopathy (MADIT-II long-term outcome[10]). The curves separate and converge overtime for nonischemic dilated cardiomyopathy (a), but continue to separate in the ischemic cardiomyopathy trial (b)

Figure 2: Total mortality between implantable cardioverter defibrillator and control arm in dilated cardiomyopathy (DANISH trial<sup>[9]</sup>) and ischemic cardiomyopathy (MADIT-II long-term outcome<sup>[10]</sup>). The curves separate and converge overtime for nonischemic dilated cardiomyopathy (a), but continue to separate in the ischemic cardiomyopathy trial (b)